Peer-reviewed veterinary case report
Dog with rare mouth plaque treated with steroids
By J.D. Rocha Júnior et al.·Published in Arquivo Brasileiro de Medicina Veterinária e Zootecnia·2025·View original on DOAJ →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Canine oral eosinophilic granuloma treated with corticosteroid monotherapy - case report
- Species:
- dog
Plain-English summary
A 5-year-old male Siberian Husky was brought in for an ulcerated plaque in his mouth, specifically on the soft palate. After a thorough examination, the vet diagnosed him with eosinophilic granuloma, a rare condition in dogs that can cause oral lesions. The treatment involved corticosteroids, specifically prednisolone, which the dog received for a week. Remarkably, he responded very well to the medication, and after completing the treatment, there were no signs of the condition returning even after 90 days.
People also search for: dog mouth ulcer treatment · Siberian Husky oral granuloma · corticosteroids for dog lesions
Abstract
ABSTRACT Eosinophilic granuloma is a lesion commonly found in cats but is rare in dogs, manifesting as nodules or plaques in the oral cavity, especially on the soft palate and tongue, with possible genetic potential involved. Due to the scarcity of descriptions of this oral lesion in dogs, especially in Brazil, the present report aimed to describe it in a Siberian Husky, treated at the Veterinary Hospital of the University of Franca, presenting an adherent and ulcerated plaque on the soft palate. Histopathological examination detected intense eosinophilic infiltrate associated with areas of collagenolysis, absence of neoplastic cells and negative PAS staining. Corticosteroid therapy with prednisolone (2mg/kg, every 24 hours, 7 days) was instituted, with gradual weaning of 0.5mg/kg, every 7 days. Given the excellent therapeutic response, this medication was maintained as monotherapy and, within 90 days of the end of treatment, there were no signs of relapse, without the need for association with complementary therapies or other therapeutic modalities, which could cause adverse effects and additional costs. It is admitted that, despite being uncommon, due to its similar clinical appearance, eosinophilic granuloma should be included in the differential diagnosis of neoplasms and infections, aiming at appropriate therapeutic institution.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on DOAJ: https://doi.org/10.1590/1678-4162-13376